Examkin

Question

Difficulty: MediumBreast Disorders

A 54-year-old postmenopausal woman presents to the physician's office after discovering a firm lump in her left breast three weeks ago. The patient has no history of breast trauma, nipple discharge, or skin dimpling. She experienced natural menopause at age 51. Her maternal aunt was diagnosed with breast cancer at age 68. Vital signs are within normal limits. Physical examination reveals a 2.5-cm, hard, irregular, and immobile mass in the upper outer quadrant of the left breast. There are no overlying skin changes, and no axillary or supraclavicular lymphadenopathy is appreciated.

Assume that subsequent evaluation confirms early-stage, estrogen receptor-positive, HER2-negative invasive ductal carcinoma, and the patient opts for breast-conserving management.

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological order for this patient.

  1. 1Perform diagnostic mammography and targeted breast ultrasound
  2. 2Obtain an image-guided core needle biopsy of the breast mass
  3. 3Perform breast-conserving surgery and sentinel lymph node biopsy
  4. 4Administer adjuvant whole-breast radiation therapy
  5. 5Initiate long-term adjuvant endocrine therapy with an aromatase inhibitor

Answer

The correct chronological sequence is: Perform diagnostic mammography and targeted breast ultrasound -> Obtain an image-guided core needle biopsy of the breast mass -> Perform breast-conserving surgery and sentinel lymph node biopsy -> Administer adjuvant whole-breast radiation therapy -> Initiate long-term adjuvant endocrine therapy with an aromatase inhibitor.
The proper sequence for managing a new palpable breast mass in a patient aged 30 or older begins with diagnostic imaging (mammography and targeted ultrasound) to characterize the lesion. If imaging indicates a suspicious mass, an image-guided core needle biopsy is necessary for definitive histologic diagnosis and receptor testing. Following a diagnosis of early-stage breast cancer, the patient undergoes definitive surgical management; breast-conserving surgery (lumpectomy) combined with sentinel lymph node biopsy is appropriate for clinically node-negative disease. Because breast-conserving surgery leaves remaining breast tissue at risk, it must be followed by adjuvant whole-breast radiation therapy to reduce local recurrence. Finally, for hormone receptor-positive tumors in postmenopausal women, long-term adjuvant systemic therapy with an aromatase inhibitor is initiated to decrease the risk of distant recurrence and contralateral breast cancer.

Step-by-Step Solution

1
Evaluate a new palpable breast mass in a patient ≥ 30 years of age.
Diagnostic mammography and targeted ultrasound are performed.
These imaging modalities are first-line for patients over 30 to characterize the lesion and evaluate for multifocal or contralateral disease prior to any intervention.
2
Obtain a definitive tissue diagnosis for a suspicious solid mass.
Image-guided core needle biopsy is performed.
Core needle biopsy is required to confirm malignancy, determine histology (e.g., invasive ductal carcinoma), and assess receptor status, which guides subsequent surgical and medical treatment.
3
Provide definitive local surgical treatment for early-stage invasive breast cancer.
Breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy is performed.
This is the surgical standard of care for early-stage breast cancer with clinically negative axillary nodes when the patient desires breast conservation.
4
Reduce the risk of local recurrence following breast-conserving surgery.
Adjuvant whole-breast radiation therapy is administered.
Radiation is a mandatory adjunct to lumpectomy because it eliminates residual microscopic disease in the remaining breast tissue.
5
Provide systemic therapy for hormone receptor-positive disease.
Adjuvant endocrine therapy with an aromatase inhibitor is initiated.
In postmenopausal women with estrogen receptor-positive tumors, systemic endocrine therapy reduces the risk of distant recurrence and contralateral breast cancer.

Key Concept

The standard evaluation and management of early-stage, hormone receptor-positive breast cancer in a woman ≥ 30 years old follows a strict chronological sequence of diagnostic imaging, tissue biopsy, surgical resection with axillary staging, local adjuvant radiation, and systemic adjuvant endocrine therapy.
Rate this question

Topics

Breast Disorders

More questions from this topic